Belgium· BE-AMP-SAM534097-00

Hemafer 100 mg

A eisen-iii-hydroxid-polymaltose komplex product containing iron (iii) hydroxide polymaltose complex, registered in Belgium by Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories. The same ATC class is registered in 8 of our 19 countries.

ATC B03AB05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedHemafer 100 mgATCB03AB05REGISTER NO.BE-AMP-SAM534097-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Eisen-iii-hydroxid-polymaltose komplex is registered in 8 of 19 countries.

Countries holding a registration under ATC B03AB05 (eisen-iii-hydroxid-polymaltose komplex), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Eisen-iii-hydroxid-polymaltose komplex · ATC B03AB05

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eisen-iii-hydroxid-polymaltose komplex costs, country by country.

Normalised to the WHO defined daily dose (90 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Eisen-iii-hydroxid-polymaltose komplex · price per daily dose (90 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.42
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Iron (III) Hydroxide Polymaltose Complex
Manufacturer
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories
Country
Belgium (BE)
ATC code
B03AB05
ATC class
Eisen-III-hydroxid-Polymaltose Komplex
Defined daily dose
90 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

78 interactions on record for eisen-iii-hydroxid-polymaltose komplex.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eisen-iii-hydroxid-polymaltose komplex · interactions on record

78 records

  • 3 severe
  • 68 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eisen-iii-hydroxid-polymaltose komplex in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eisen-iii-hydroxid-polymaltose komplex products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Bulgaria · Айронлек Адифарм
  • Czechia · Maltofer
  • Greece · Dextrifer, Feralice
  • Hungary · Maltofer
  • Italy · Intrafer
  • Romania · Ferrum Hausmann, Maltofer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dbed6346-0e20-45a4-9964-3ace07dc5d8c
GET /v1/drugs/dbed6346-0e20-45a4-9964-3ace07dc5d8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Chewable tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Hemafer 100 mg",
  "name_fr": "Hemafer 100 mg",
  "name_nl": "Hemafer 100 mg",
  "amp_code": "SAM534097-00",
  "strengths": [
    "357.0000",
    "100.0000",
    "9.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Iron (III) Hydroxide Polymaltose Complex",
    "Iron",
    "Sodium Cyclamate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ferric Oxide Polymaltose Complexes",
  "authorisation_numbers": [
    "BE534097"
  ]
}

See everything about eisen-iii-hydroxid-polymaltose komplex.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.